<?xml version="1.0" encoding="UTF-8"?>
<ref id="bb0220">
 <label>43</label>
 <note>
  <p>Palivizumab, a humanized respiratory syncytial virus monoclonal antibody, reduces hospitalization from respiratory syncytial virus infection in high-risk infants. The IMpact-RSV Study Group. Pediatrics. 1998;102(3 Pt 1):531â€“7. 
   <ext-link ext-link-type="uri" xlink:href="pmid:9738173" id="ir0290" xmlns:xlink="http://www.w3.org/1999/xlink">9738173</ext-link>; .
  </p>
 </note>
</ref>
